Molecular and Clinical Findings in Patients With Knobloch Syndrome by Hull, S et al.
Copyright 2016 American Medical Association. All rights reserved.
Molecular and Clinical Findings in Patients
With Knobloch Syndrome
Sarah Hull, MA, FRCOphth, PhD; Gavin Arno, PhD; Cristy A. Ku, PhD; Zhongqi Ge, PhD; NaushinWaseem, PhD;
Aman Chandra, FRCOphth, PhD; Andrew R.Webster, MD(Res), FRCOphth; Anthony G. Robson, MSc, PhD;
Michel Michaelides, MD(Res), FRCOphth; Richard G. Weleber, MD; Indran Davagnanam, MD(Res), FRCR;
Rui Chen, PhD; Graham E. Holder, MSc, PhD; Mark E. Pennesi, MD, PhD; Anthony T. Moore, MA, FRCOphth
IMPORTANCE Knobloch syndrome is a rare, recessively inherited disorder classically
characterized by highmyopia, retinal detachment, and occipital encephalocele, but it is now
known to have an increasingly variable phenotype. There is a lack of reported
electrophysiologic data, and some key clinical features have yet to be described.
OBJECTIVE To expand on current clinical, electrophysiologic, andmolecular genetic findings
in Knobloch syndrome.
DESIGN, SETTING, AND PARTICIPANTS Twelve patients from 7 families underwent full
ophthalmic examination and retinal imaging. Further investigations included
electroretinography and neuroradiologic imaging. Bidirectional Sanger sequencing of
COL18A1was performedwith segregation on available relatives. The study was conducted
from July 4, 2013, to October 5, 2015. Data analysis was performed fromMay 20, 2014, to
November 3, 2015.
MAIN OUTCOMES ANDMEASURES Results of ophthalmic and neuroradiologic assessment and
sequence analysis of COL18A1.
RESULTS Of the 12 patients (6males; mean age at last review, 16 years [range, 2-38 years]), all
had highmyopia in at least 1 eye and severely reduced vision. A sibling pair had unilateral high
myopia in their right eyes and near emmetropia in their left eyes from infancy. Anterior
segment abnormalities included absent iris crypts, iris transillumination, lens subluxation, and
cataract. Two patients with iris transillumination had glaucoma. Fundus characteristics
included abnormal collapsed vitreous, macular atrophy, and a tesselated fundus. Five patients
had previous retinal detachment. Electroretinography revealed a cone-rod pattern of
dysfunction in 8 patients, was severely reduced or undetectable in 2 patients, and
demonstrated cone-rod dysfunction in 1 eye with undetectable responses in the other eye in
2 patients. Radiologic imaging demonstrated occipital encephalocele or meningocele in 3
patients, occipital skull defects in 4 patients, minor occipital changes in 2 patients, and no
abnormalities in 2 patients. Cutaneous scalp changes were present in 5 patients. Systemic
associations were identified in 8 patients, including learning difficulties, epilepsy, and
congenital renal abnormalities. Biallelic mutations including 2 likely novel mutations in
COL18A1, were identified in 6 families that were consistent with autosomal recessive
inheritance with a single mutation identified in a family with 2 affected children.
CONCLUSIONS AND RELEVANCE This report describes new features in patients with Knobloch
syndrome, including pigment dispersion syndrome and glaucoma as well as cone-rod
dysfunction on electroretinography. Two patients had normal neuroradiologic findings,
emphasizing that some affected individuals have isolated ocular disease. Awareness of the
ocular phenotypemay aid early diagnosis, appropriate genetic counseling, andmonitoring
for potential complications.
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K nobloch syndrome is a rare, recessively inherited dis-order first described in 1971 in a family affected by vit-reoretinaldegeneration, retinaldetachment,highmyo-
pia, occipital encephalocele, and lens subluxation.1Additional
ocular features have since been identified, including cata-
ract, smooth irides, and persistent fetal vasculature.2-4 Lim-
ited electrophysiologic characterization has been reported5,6
in 3 patients. Neuroradiologic imaging has revealed a variety
of developmental brain anomalies including occipital skull
defects with or without encephalocele, polymicrogyria, sub-
ependymal nodules, and cerebellar vermis atrophy.5,7-10 Ad-
ditional systemic findings includeepilepsy,developmentalde-
lay, and renal abnormalities.2-4,7,10-14
The Knobloch locus was mapped to 21q22.3 in 1996 and
COL18A1wassubsequently identifiedas thecausativegene.15,16
TheCOL18A1geneencodes the collagenα-1(XVIII) chain,ubiq-
uitously expressed in vascular and epithelial basement
membranes.17,18 Collagen XVIII has multiple functions in
ocular and neurologic development, including angiogenesis,
basementmembranemaintenance, and in theWnt/β-catenin
signaling pathway.17 The present report describes the de-
tailed phenotypes and molecular genetic findings in 12 af-
fected individuals of 7 families with Knobloch syndrome.
Methods
Families in which 1 or more member had clinical features of
Knobloch syndrome were identified from the inherited reti-
nal clinics at Moorfields Eye Hospital and the Oregon Health
& Science University Casey Eye Institute. Each affected indi-
vidual underwent a full clinical examination including visual
acuity and dilated fundus examination. Retinal imaging was
obtained by 35° (Topcon Great Britain Ltd), or 60° color fun-
dus photography (Canon USA Inc), ultra-widefield confocal
scanning laser imaging (Optos plc), RetCam imaging (Clarity
Medical Systems Inc), 30° or 55° fundus autofluorescence
imaging (Spectralis, Heidelberg Engineering Ltd), and spec-
tral domain optical coherence tomography scans (Spectra-
lis). Full field electroretinography (ERG) was performed in
older children and adults to incorporate the International
Society for Clinical Electrophysiology of Vision standards
using gold foil electrodes (Moorfields Eye Hospital) or Burian
Allen electrodes (Oregon Health & Science University);
recording in infants and young children was performed
with surface electrodes as previously described.19-23 Pattern
ERG was performed in the patients from Moorfields Eye
Hospital.24 Eleven patients underwent radiologic imaging of
the brain, either bymagnetic resonance imaging or computed
tomography.
The study protocol adhered to the tenets of the Declara-
tion ofHelsinki25 andwas approved by theResearchManage-
ment Committee at Moorfields Eye Hospital, London, En-
gland, and the institutional review board at Oregon Health &
ScienceUniversity,Portland.Written informedconsentwasob-
tained from all participants prior to study inclusion, with pa-
rental written consent provided on behalf of the children in-
volved. There was no financial compensation.
The studywas conducted from July 4, 2013, to October 5,
2015. Data analysis was performed from May 20, 2014, to
November 3, 2015.
Molecular Biology
Bidirectional Sanger sequencing of all 41 exons and intron-
exon boundaries of the medium isoform of COL18A1 (Gen-
Bank NM_030582.3) was performed in an affected proband
from families 1 to 4 and segregation confirmed in the affected
sibling and available relatives. The DNA was amplified using
specifically designed primers by polymerase chain reaction,
and the resulting fragments were sequenced using standard
protocols (eTable 1 in the Supplement). Patients 1.1 and 5 had
previously undergone arrayed primer extension microarray
(Asper Biotech Ltd), performed using a genotyping microar-
ray containingmore than 700disease-causing variants for 28
retinal dystrophy genes.26
Patients 5, 6.1, 6.2, and 7 underwent whole-exome se-
quencing (WES)with identifiedvariants thenconfirmedbybi-
directional Sanger sequencing in the affected probands and
available relatives.AdiagnosisofKnoblochsyndromewasclini-
cally suspected in patients 6.1, 6.2, and 7 prior toWESbut not
in patient 5. For patient 5, WES was performed at AROS Ap-
plied Biotechnology using a solution-phase Agilent SureSe-
lect 38Mbexomecapture (SureSelectHumanAllExonKit,Agi-
lentTechnologies Inc) and the IlluminaHiSeq2000sequencer
(Illumina Inc). Reads were aligned to the hg19 human refer-
ence sequenceusingNovoalign (Novocraft), version2.05. The
ANNOVAR tool (OpenBioinformatics.org) was used to anno-
tate single-nucleotide polymorphisms and small insertions/
deletions.Patients6.1,6.2, and7underwentWESatBaylorCol-
legeofMedicineusingNimbleGenSeqCapEZhybridizationand
wash kit (NimblegenSeqCap EZ human exome library, ver-
sion 2.0) according to the manufacturer’s instructions. Illu-
minaHiSequation2000 (Illumina)wasused to sequence cap-
tured libraries. Bioinformatics analysis was performed as
described previously.27 Further filtering of variants was per-
formed based on a frequency higher than 0.5% in a series of
public and internal databases, including Exome Aggregation
Consortium (ExAC).
Key Points
Question What potentially novel clinical andmolecular features
are identified from an investigation of 12 patients with Knobloch
syndrome?
Findings In this case series, the features identified included
pigment dispersion syndrome and glaucoma, cone-rod
dysfunction on electroretinography, and 2mutations that, to our
knowledge, have not been previously reported. All patients had
severe visual impairment, myopia, andmacular atrophy; in
addition, 5 individuals had retinal detachment and 2 had normal
findings of neuroradiologic imaging.
Meaning Awareness of the clinical features of Knobloch
syndromemight facilitate diagnosis andmonitoring for potential
complications.
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Mutation nomenclaturewas assigned in accordancewith
GenBankaccessionnumberNM_030582.3,withnucleotidepo-
sition1corresponding to theAof theATGinitiationcodon.Vari-
ants were identified as novel if not previously reported in the
literature and if absent fromdbSNP (http://www.ncbi.nlm.nih
.gov/projects/SNP/), NHLBI GO Exome Sequencing Project
(http://evs.gs.washington.edu/EVS/), 1000 Genomes Project
(http://www.1000genomes.org/), and ExAC (http://exac
.broadinstitute.org); all sites were accessed December 29,
2015.28 These databases were also interrogated using the
mutations transcribed for the alternate short isoform also
reported in the literature (GenBank NM_130445.2). Variants
likely to affect function were assessed for segregation in
available family members. Potential splice variants were
assessedusing Splice Site PredictionbyNeuralNetwork (http:
//www.fruitfly.org/seq_tools/splice.html) andHumanSplicing
Finder (http://www.umd.be/HSF3/).29,30
Results
Key clinical features are summarized in theTable. Twelve pa-
tients from 7 families (Figure 1) were evaluated; their ages at
the last review ranged from2 to 38 years (mean [SD], 16 [9.9];
median, 15.5 years). All patientshadpresented in infancywith
nystagmus and variable convergent or divergent squints ex-
cept for patient 3.2,whowas orthophoric. All patients had se-
vere visual impairment with best-corrected visual acuity in
Table. Key Clinical Features of Affected Patients
Patient No./Sex/
Ethnic Origin/
Genetic Database No.
Age at
Last
Review, y
Visual Acuity,
logMAR
(Snellen
equivalent)
Refraction, Under
Cycloplegiaa
Anterior Segment
Features
Posterior Segment
Features
Neurologic and/or
Systemic Features
1.1/M/Indian/GC14449 23 R NPL, L CF R −17.50 DS, L +1.0 DS
(atropine 1998)
Absent iris crypts, poor
pupillary dilatation
Retinal detachment,
R paracentral,
circumscribed CR
atrophy, L generalized
retinal and RPE atrophy
Subgaleal fat pad,
polymicrogyria;
epilepsy, developmental
delay
1.2/F 21 R
1.3 (20/
400), L PL
R −13.5/−1.00 × 180,
L +0.75/−1.00 × 180
(subjective 2002)
Absent iris crypts,
persistent pupillary
membrane, poor
pupillary dilatation
R paracentral,
circumscribed CR
atrophy, L generalized
retinal and RPE atrophy
Midline occipital defect,
atretic encephalocele,
polymicrogyria; none
2.1/M/British, white
GC19526
14 R
1.9 (20/
1600), L NPL
R −18.00/−2.00 × 15,
L +9.00 DS
Persistent pupillary
membrane, poor
pupillary dilatation, iris
transillumination
Retinal detachment,
generalized, ill-defined
macular CR atrophy BE
Normal; hypermobile
joints
2.2/M 11 R
1.6 (20/
800), L
1.4 (20/500)
R −24.00/−2.00 × 10L
+3.00/−1.50 × 15
Persistent pupillary
membrane, poor
pupillary dilatation, iris
transillumination, lens
subluxation
Paracentral
well-defined CR
atrophy BE
Resected occipital
encephalocele,
polymicrogyria;
hypermobile joints
3.1/M/Slovak/GC20422 17 R
1.6 (20/
800), L
1.4 (20/500)
R +12.00/−2.00 × 100,
L −10.00/−6.00,
0 × 110
(subjective 2014)
Absent iris crypts, poor
pupillary dilatation,
cortical lens opacity,
lens subluxation
Paracentral ill defined
retinal and RPE
atrophy BE
Midline occipital defect;
learning difficulties
3.2/F 11 R
1.2 (20/
320), L
1.4 (20/500)
R −20.00/−2.00 × 100,
L −19.00/−2.00 × 180
Absent iris crypts, poor
pupillary dilatation,
cortical lens opacity,
lens subluxation
Paracentral CR atrophy,
well defined on R,
ill-defined on L
Occipital lobe
corticated channel;
none
4.1/F/Arab/GC20693 4 R
2.1 (<20/
2000), L
2.1 (<20/2000)
R −12.00/−2.00 × 10,
L −12.50 DS
None Central, ill-defined CR
atrophy BE
Midline occipital defect;
congenital
hydronephrosis,
hypermobile joints
4.2/M 2 R PL, L NPL Not performed Cortical lens opacity Retinal detachment,
central, ill-defined CR
atrophy BE
Midline occipital defect;
hypermobile joints
5/F/British,
white/GC18840
38 R
1.06 (20/
250), L
1.06 (20/250)
R −35 DS, L −28 DS
(before lens removal)
Poor pupillary
dilatation, iris
transillumination,
cortical lens opacity,
lens subluxation
Paracentral, well
defined, deep large CR
atrophy on R, smaller
and ill-defined on L
Normal; unilateral
duplex kidney/bifid
ureter, hamstring
sarcoma
6.1/F/Northern European 19 R CF, L CF R −13.00 DS, L −14.00
DS (subjective 2006)
Iris transillumination,
cortical lens opacity
Central ill-defined CR
atrophy BE
Resected occipital
meningocele; vertigo
6.2/M 24 R
1.4 (20/
500), L CF
R −10.00 DS, L −10.00
DS (subjective 2008)
Poor pupillary
dilatation, iris
transillumination
cortical lens opacity
Retinal detachment,
paracentral,
well-defined CR
atrophy BE
None known; occipital
cutaneous alopecia
7/F/African 4 R
1.6 (20/
800), L
1.5 (20/600)
R −1.50/+1.00 × 87,
L −0.50/+1.25 × 89
(subjective 2011)
Poor pupillary dilatation Retinal detachment,
R paracentral,
well-defined CR
atrophy, L detached
with macular hole
Resected occipital
encephalocele; none
Abbreviations: BE, both eyes; CR, chorioretinal; CF, counting fingers; DS, diopter sphere; L, left; NPL, no perception of light; PL, perception of light R, right;
RPE, retinal pigment epithelium.
a Parenthetical information indicates the use of a different refractionmethod.
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each eye at last review ranging from 1.06 logMAR (Snellen
equivalent 20/250) to no perception of light. Patient 1.2 had
stable vision of 1.3 logMAR (Snellen equivalent 20/400) OD
from the first review at age 9 years to the last review at age 21
years; patient 5 also had stable vision of 1.06 logMAR (Snel-
len equivalent 20/250) in each eye over a 36-year review pe-
riod. Patient 6.2 had stable vision of 1.4 logMAR (Snellen
equivalent 20/500)ODover an8-year review,with the left eye
developing a chorioretinal scar after detachment surgery that
reduced his vision. All patients had highmyopia (−6 diopters
or more) in at least 1 eye, with high myopia reported in pa-
tients 4.2 and 5 before cataract extraction. Five patientswere
anisometropicwithhighmyopia in 1 eye andhyperopia in the
other. This anisometropia was related to lens subluxation in
2patients (2.2 and3.1), unilateral retinal detachmentwithhy-
peropic shift in 1 patient (2.1), and unilateral high myopia in
the right eye with near emmetropia in the left eye from in-
fancy in2 siblingsunrelated to retinaldetachment (1.1 and 1.2).
These siblingshadasymmetrical axial lengths asmeasuredby
B-scan ultrasonography at age 8 years for patient 1.1 and 19
years for patient 1.2 when the length of themyopic eyes were
26.7 and 27.9mm and that of the emmetropic eyes were 20.7
and 21.1 mm, respectively. These siblings were previously
reported31whenchildren;newdata in this report, 15years later,
include visual acuity, additional ERG tests, anterior segment
and fundus features, and neuroradiologic findings.
Anterior segment abnormalities were present in all par-
ticipants except patient 4.1, who was examined at age 4
years. Abnormalities includedpoor pupillary dilatation (8 pa-
tients), absence of crypts associated with a featureless iris (5
patients), iris transillumination (5patients), andpersistentpu-
pillary membrane (3 patients) (Figure 2). Seven patients had
cataracts with 2 requiring cataract extraction. Three patients
had lens subluxation in the inferotemporal directionwith pa-
tient 5 reported to have lens subluxation prior to cataract ex-
traction. All 5 patients of Northern European origin (families
2, 5, and 6), had iris transillumination with all but patient 6.1
developingraised intraocularpressure.Glaucomatousdisccup-
ping was identified in 1 eye of patients 2.1 at age 11 years and
6.2 at 22 years; neither had lens subluxation. Patient 5, in ad-
dition to iris transillumination, had endothelial pigment
(Krukenberg spindles), pigment on the lens capsule andheav-
ily pigmented angles on gonioscopy, all consistent with a
diagnosis of pigment dispersion syndrome. Endothelial
pigment was also noted in patient 6.2.
All highly myopic eyes had disc pallor, attenuated ves-
sels, a markedly tessellated appearance with prominent cho-
roidal vessels, peripapillary atrophy, and occasional pig-
mented spots (Figure 2); 2 eyes had staphylomas. The
emmetropic left eyes of patients 1.1 and 1.2 were heavily pig-
mented.Abnormalvitreous condensationswerenoted in9pa-
tients.Macular atrophywas present in 23 of 24 eyes, with the
left eye of patient 7 having detached centrally with amacular
hole at initial assessment (Table). The atrophywas chorioreti-
nal in most patients, involving the outer retina, retinal pig-
mentepithelium,andchoroid. In 13eyes theatrophywaspara-
central, being well circumscribed in 9 of 13 eyes; in 10 eyes it
was central and ill defined (Figure 2). In patientswithout cen-
tral macular atrophy, poor foveal reflexes were noted. Three
patients developed bilateral retinal detachments and 2 pa-
tientsdevelopedunilateral detachment.Optical coherence to-
mography findings of the posterior polewas available in 6pa-
tients. All scans showed a lack of foveal pits, extensive loss of
outer retinal structure and, in 4 patients, additional atrophy
Figure 1. Pedigrees of Families Affected by Knobloch SyndromeWith Segregation Analysis
and First Report of theMutation
Family 1
Homozygous
c.4063_64delCT
(p.Leu1355Valfs*72)
Suzuki 2002
WT/M M/WT
M/M
1.1
M/M
1.2
Family 2
Compound het
M1 c.2437-2A>G
ExAC: 1 in 120 452,
M2 c.3213delC
(p.Gly1072Aspfs*17)
ExAC: 3 in 22 692
Family 3
Homozygous
c.3459dupC
(p.Gly1154Argfs*110)
novel
Family 4
Homozygous
c.3356_7insT
(p.Gly1122Argfs*145)
novel
Family 5
Homozygous
c.3213dupC
(p.Gly1072Argfs*9)
Suzuki 2009)
Family 6
Heterozygous
c.2658dupC
(p.Gly887Argfs*23)
Aldahmesh 2013
Family 7
Homozygous
c.4173G>A (p.=)
ExAC 1 in 60 334
M1/WT
M2/WT M1/M2
2.1
M1/M2
2.2
M/WT WT/M
M/M
3.1
M/WT M/M
3.2
M/WT
M/WT WT/M
M/M
4.1
M/M
4.2
WT/M M/WT
M/WT M/M
5
M/WT
M/WT
M/WT
6.1
M/WT
6.2
M/M
7
Affected female
Affected male
Spontaneous 
miscarriage
M indicates mutation; WT, wild-type.
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of the retinal pigment epithelium and choroid. Fundus auto-
fluorescence imaging findings, available in 5 patients, dem-
onstratedwell-circumscribed loss of posterior pole autofluo-
rescence.
Electroretinography showed cone-rod dysfunction in 18
eyes (10 patients) and severely reduced or undetectable
responses in 6 eyes (4 patients) (Figure 3). Patients 1.1 and
1.2 at initial testing in 2002 had undetectable ERGs in their
Figure 2. Anterior Segment and Retinal Imaging in Knobloch Syndrome
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Patient 1.2 at age 21 years: left (L)
anterior segment photograph (A),
right (B) and left (C) color fundus
photographs (Topcon Great Britain
Ltd). Patient 2.2 at age 14 years: left
anterior segment photograph (D), left
Optos wide field color (E), and left
Optos autofluorescence imaging
(Optos plc) (F). Patient 3.2 at age 11
years: left anterior segment
photograph (G), right wide field
imaging (Optos plc) (H), and right (I)
and left (J) optical coherence
tomography (OCT) (Spectralis).
Patient 5 at age 38 years: right
anterior segment photograph (K),
right fundus photograph (Topcon
Great Britain Ltd) (L), right
autofluorescence imaging (Spectralis)
(M), and right OCT (N). Patient 6.2 at
age 11 years: right anterior segment
photograph (O) to demonstrate
vitreous clumping, and right (P) and
left (Q) fundus color photographs.
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emmetropic left eyes with cone dysfunction more than rod
dysfunction in their myopic right eyes. Additional ERG
in 2014 in patient 1.1 showed undetectable ERGs in
both eyes, with the right having developed a total retinal
detachment and the left showing a peripheral detachment.
Additional ERG in patient 1.2 showed marked deteriora-
tion, particularly of cone responses in the right eye,
but with stable visual acuity. Electroretinography was unde-
tectable in patient 4.2 who was tested under general anes-
thesia with silicone oil in both vitreous cavities. Patient 7
Figure 3. Electroretinogram (ERG) of 1 Eye of Patients 3.2, 6.1, 6.2, and 7
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In patient 3.2 (A), rod-specific (dark-adapted [DA] 0.01) ERG is mildly
subnormal; bright flash (DA 10.0) a-wave amplitude is subnormal; cone flicker
(light-adapted [LA] 30 Hz) and single-flash (LA 3.0) ERGs are markedly
subnormal and delayed (note the differences in calibration compared with the
normal); pattern ERG (PERG) is undetectable. In patients 6.1 (B) and 6.2 (C),
rod-specific and bright flash amplitudes are subnormal, cone flicker and single
flash are markedly subnormal and delayed; abnormalities are more severe for
patient 6.2, partly related to sedation required for the ERG. Patients 3.2, 6.1, and
6.2 show a cone-rod pattern of dysfunction; patient 7 (D) has severe loss of
both rod and cone responses. Normal ERG (E) is shown for comparison. Div
indicates division.
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had severely reduced ERG in both eyes, with retinal detach-
ment in the left eye.
Neuroradiology was performed in 11 patients (Figure 4).
Imaging results were normal in 2 patients. Four patients had
occipital skull defects and3hadoccipital encephaloceleorme-
ningocele.Minor abnormalities in 2patients comprised anoc-
cipital subgaleal fat pad and a corticated (covered in cortical
bone) small channel in the occipital lobe, possibly represent-
ing an atretic encephalocele. Three patients had polymicro-
gyria.The imaging resultsdifferedbetweensiblings inall fami-
lies except family 4. Cutaneous occipital abnormalities were
present in5patients, includingpalpable swelling, alopecia, and
a patch of white hair. Systemic abnormalities included learn-
ing difficulties, epilepsy, congenital hydronephrosis due to a
ureteric abnormality, and duplex kidney with bifid ureters in
patient 5, who also had undergone treatment for a hamstring
sarcoma.
Biallelic variants in COL18A1 predicted to be pathogenic
were identified in 5 families, with a single heterozygous vari-
ant in thesixth familyandahomozygous, synonymouschange
in the seventh family. Segregationwas confirmed in available
family members (Figure 1). To our knowledge, 2 novel muta-
tions were identified with 3 additional mutations not previ-
ously reported in an affected patient but found at a very low
Figure 4. Neuroradiologic and Cutaneous Occipital Findings in Knobloch Syndrome
T1-weighted sagittal MRIA T2-weighted axial MRIB T2-weighted axial MRIC T1-weighted sagittal MRID T2-weighted axial MRIE
T1-weighted sagittal MRIF External photograph 
of scalp
G T1-weighted sagittal MRIH T1-weighted sagittal MRII T1-weighted coronal MRIJ
Patient 1.1 Patient 1.2
Patient 2.1 Patient 2.2
Sagittal CTK External photograph of scalpMT1-weighted sagittal MRIL T1-weighted sagittal MRIN T1-weighted 
axial MRI
O
Patient 3.2 Patient 7Patient 4.1 Patient 6.2
Patient 1.1: subgaleal fat pad (arrowheads) overlying occipital bone (A and B)
and extensive bifrontal polymicrogyria (arrowheads) (C) onmagnetic resonance
imaging (MRI). Patient 1.2: small occipital bone defect (arrowhead) with atretic
encephalocele/meningocele (D) andmedial bifrontal polymicrogyria
(arrowheads) (E) onMRI. Patient 2.1: no abnormalities onMRI (F) and occipital
patch of white hair (G). Patient 2.2: aged 6months, occipital encephalocele
(arrowhead) onMRI (H), age 11 years, occipital scarring and retained
retrocerebellar arachnoid cyst at site of previous surgery (arrowhead) (I), and
age 11 years, bilateral inferior frontal polymicrogyria (arrowhead) (J) onMRI.
Patient 3.2: small, well-corticated channel in themidline of the occipital lobe
(arrowhead) (K) on computed tomographic scan. Patient 4.1: small bony
occipital defect (arrowhead) with meningeal tissue communicating to
subcutaneous tissue through the defect (L) onMRI. Patient 6.2: cutaneous
alopecia overlying occiput (M). Patient 7: age 4months, occipital encephalocele
(arrowhead) (N and O) onMRI. TheMRIs were intracranial sagittal and coronal
T1-weighted and axial T2-weighted images.
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mean allele frequency in the ExAC database (Figure 1). Eight
mutations,6 thatcreatepremature terminationcodons,asplice
sitemutation, anda synonymousvariantwere identified. The
splice sitemutation, c.2437-2A>G,which is very rare onExAC
(1 in 120452), disrupts the canonical acceptor site for exon 17.
The heterozygous variant identified in family 6, c.2658dupC
(p.Gly887Argfs*23), has beenpreviously reported.32 The syn-
onymousvariant, c.4173G>A,was foundhomozygously inpa-
tient7and isvery rareonExAC(1 in60334alleles).The insilico
splice predictions for this variantwere equivocal; theHuman
SplicingFinder algorithmsuggesting that anexonic cryptic ac-
ceptor sitemayhavebeen createdwasnot replicated byother
algorithms (Splice Site PredictionbyNeuralNetwork).Whole-
exomesequencing inpatients6.1, 6.2, and7 identifiednoother
potentially pathogenic variant inCOL18A1or anyother known
retinal dystrophy genes.
Discussion
The classic description of Knobloch syndrome includesmyo-
pia, retinaldetachment, andoccipital encephalocele, butmore
recent publications5,10,32 have described an increasingly vari-
able ocular and systemic phenotype. Thepresent report,with
detailed retinal imaging, ERG, and neuroradiology in a large
series, has allowed a detailed assessment of the clinical phe-
notype. To our knowledge, this is the first report of the elec-
trophysiologic finding of cone-rod dysfunction and first de-
scription of childhood-onset glaucoma associated with iris
transillumination.
All patients presented in infancywithnystagmus andhad
high myopia in at least 1 eye. Three patients had inferotem-
poral lens subluxation consistentwith a previous report.5 Iris
abnormalities were also common. Absence of iris crypts and
asinglecaseof irisatrophyhavebeendescribedpreviously.3-5,32
In a knockout mouse model COL18a1−/−, there was disrup-
tion of the posterior iris pigment epithelial cell layer and re-
lease of melanin granules that resembled the human pig-
ment dispersion syndrome.33 Two patients in our series with
clinical features of pigment dispersion syndrome had associ-
ated glaucoma.34 This association suggests an increased risk
of pigmentary glaucoma in white patients with Knobloch
syndrome.
Manyof the retinal changesnoted in this series are consis-
tentwith highmyopia and are not specific to the syndrome.35
Thesechanges includeperipapillaryatrophyandthetessellated
fundusappearancewithprominentchoroidalvessels.Although
vitreous abnormalities are seen in highmyopia, the collapsed
abnormalvitreouspresent inourpatients fromayoungagemay
relate to theunderlyingdisorder.Macular atrophywas identi-
fied inallpatients.Thisabnormalitycanalsooccur inhighmyo-
piawithdiffuseatrophyor focal areasof atrophy; the latterwas
shown to develop in the fifth decade in a large natural history
study.36Theyoungageof thepatients in thepresent studysug-
gests that the atrophic lesions are likely tobea consequenceof
mutations inCOL18A1.Macular atrophic lesions andabnormal
vitreouscondensationshavebeenpreviously reported5,7,32 and
may be key features of the disorder.
Previous electrophysiology reports on Knobloch syn-
drome are limited; delayed and depressed photopic and sco-
topic ERGs were observed in 2 children in 1 report,5 but few
detailson techniqueoramplitudeof responsesweregiven, and
a severely diminished ERG was described in 1 patient in an-
other report.6 The present series with detailed electrophysi-
ologic testing of all affected patients demonstrates both cone
and roddysfunction.Additional ERG inpatient 1.2 showedde-
terioration but stable visual acuity. It therefore remains un-
clear whether Knobloch syndrome represents a progressive
dystrophy of photoreceptors or a stable dysfunction; how-
ever, progression, if present, appears to be asymptomatic and
slow. Inourpatientswith long-term follow-up, therewas little
deterioration in visual acuity unless complicated by retinal
detachment.
COL18A1 encodes the collagen α-1(XVIII) chain, which is
highlyexpressed throughout thehumaneye including the iris,
ciliary body, trabecularmeshwork, Schlemm canal, the inner
limitingmembrane, retinalvessels,basementmembraneof the
retinal pigment epithelium, and Bruchmembrane, but not in
photoreceptors.18 The inner limitingmembrane and vitreous
body are important regulators of eye size in a chick embryo
model with disruption of these structures leading to eye en-
largement. This finding could explain thehighmyopia seen in
Knoblochsyndromeasevidencedbythehighaxial lengthmea-
sured in themyopiceyesof family 1.37 Inmice, lackof typeXVIII
collagencauses abnormal vitreous separation, consistentwith
the abnormal vitreous and retinal detachment found in hu-
man disease.38 The underlying pathogenesis of photorecep-
tor dysfunction is not clear from animal models but the ab-
normal Bruch’s membrane, retinal pigment epithelium, and
inner limitingmembranewould be predicted to have second-
ary effects on the photoreceptors.38 Alternatively the distri-
bution and function of type XVIII collagen may differ in the
human eye.
Occipital encephalocele or meningocele is reported39 to
be common in Knobloch syndrome but was identified in
only 3 patients in the present series. Normal neuroimaging
has previously been reported7,12 in 2 patients; to our knowl-
edge, the additional minor abnormality of a subgaleal fat
pad is a new observation. Five patients had externally
observable occipital findings, ranging from soft-tissue
swellings to hair abnormalities, emphasizing the impor-
tance of occipital scalp examination if Knobloch syndrome
is suspected.7,10,13,30 In 1 patient, a cutaneous scalp abnor-
mality was identified in the absence of neuroradiologic
abnormality. This abnormality has been previously reported
in a single patient.12 Polymicrogyria was identified on
magnetic resonance imaging in 3 patients (1.1, 1.2, and 2.2);
this feature has now been reported in several patients with
Knobloch syndrome.3,8-10
Type 18 collagen is found inmany different tissues and it
is unsurprising thatmutations inCOL18A1may result in a var-
ied systemic phenotype. Systemic associations in the present
series include epilepsy, learning difficulties, congenital hy-
dronephrosis, and unilateral duplex kidneywith bifid ureter.
There have been several reports5,7,10,14,32,40 of epilepsy in
patients with Knobloch syndrome. Renal abnormalities in
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Knobloch syndrome are unusual, with 2 previous reports2,13
of congenital duplex kidney and bifid ureter. Sarcoma,
present in 1 patient, has not been previously reported in
Knobloch syndrome, although there has been 1 case of acute
lymphoblastic leukemia.41 Those reports and the present
series highlight the importance of systemic assessment.
The COL18A1 gene consists of 43 exonswith 3main alter-
nate isoformsproduced.17,42Therehavebeen22previously re-
ported likely pathogenic mutations in COL18A1 leading to re-
cessively inherited disease, 17 of which create premature
termination codons, 2 large deletions encompassing at least a
whole exon, and 3 splice site mutations, which may indicate
that this syndrome represents a null phenotype (eTable 2 in
theSupplement). Thec.4063_4064delCTmutation is themost
common, found in 14 families todate.9,10,14,32,40,41,43,44Thedi-
verseethnicoriginsof thereportedfamilies include Indian,Bra-
zilian,NorthAmerican, Saudi, Irish, Pakistani, andTurkish in
keepingwithamutationalhotspot—nota foundereffect.A fur-
ther 5 disease-causingmutations were identified in the pres-
ent series. A singlemutationwas identified in family 6 in this
report; there may be a large structural variant, such as an ex-
onic deletion on the second allele, that is not identifiable by
direct sequencing. The synonymous variant found in patient
7mayaffect splicing,but further confirmatory functional stud-
ies are needed.
Conclusions
Knobloch syndrome is a systemic disorderwith variable neu-
rologic involvement and severe visual impairment fromearly
childhood. The syndromemay be undiagnosedwithout care-
ful examination of the anterior segment and awareness of the
potential lack of scalp and/or intracranial occipital abnormali-
ties. Thediagnosismight be considered in anypatientwith in-
fantile-onsethighmyopia,developmental abnormalitiesof the
anterior segment, and evidence of cone-rod dysfunction on
ERG. A timely diagnosis not only ensures that patients are
aware of the potential complications of the disorder, such as
lens subluxation, retinal detachment, andglaucoma, butmay
facilitate targeted molecular sequencing and informed ge-
netic counseling.
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